COMPOUNDS FOR THE TREATMENT OF DEMYELINATING AND AUTOIMMUNE DISEASES
摘要
The invention relates to the treatment of autoimmune and demyelinating diseases and, in particular, the treatment of multiple sclerosis. The treatment consists of the administration of P2X purinergic receptor antagonists, which leads to a remission of the symptoms associated with said type of diseases. The aforementioned result has been demonstrated using both in vitro cell models and animal models.
申请公布号
CA2534868(A1)
申请公布日期
2005.02.17
申请号
CA20042534868
申请日期
2004.08.04
申请人
UNIVERSIDAD DEL PAIS VASCO - EUSKAL HERRIKO UNIBERTSITATEA
发明人
ALBERDI ALFONSO, ELENA;MATUTE ALMAU, CARLOS;SANCHEZ GOMEZ, MARIA VICTORIA;TORRE MARTINEZ, IRATXE;PEREZ CERDA, FERNANDO;DOMERCQ GARCIA, MARIA;PEREZ SAMARTIN, ALBERTO